Of Mice and Men (original) (raw)

• Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004 Aug; 3(8): 711–5
  Article PubMed CAS Google Scholar
• Alzheimer Research Forum. Live discussion: mice on trial? Issues in the design of drug studies [online]. Available from URL: http://www.alzforum.org/res/for/journal/detail.asp?liveID=168 [Accessed 2009 Jul 23]
• Akhtar AZ, Pippin JJ, Sandusky CB. Animal models in spinal cord injury: a review. Rev Neurosci 2008; 19(1): 47–60
  PubMed Google Scholar
• Moghaddam B, Adams BW. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998 Aug 28; 281(5381): 1349–52
  Article PubMed CAS Google Scholar
• Ryman D, Lamb BT. Genetic and environmental modifiers of Alzheimer’s disease phenotypes in the mouse. Curr Alzheimer Res 2006 Dec; 3(5): 465–73
  Article PubMed CAS Google Scholar
• Lassalle JM, Halley H, Daumas S, et al. Effects of the genetic background on cognitive performances of TG2576 mice. Behav Brain Res 2008 Aug 5; 191(1): 104–10
  Article PubMed CAS Google Scholar
• Gloriam DE, Fredriksson R, Schiöth HB. The G protein-coupled receptor subset of the rat genome. BMC Genomics 2007 Sep 25; 8: 338–45
  Article PubMed Google Scholar
• PDSP. NIMH Psychoactive Drug Screening Program [online]. Available from URL: http://pdsp.med.unc.edu/ [Accessed 2009 Jul 23]
• Sullivan RM. Hemispheric asymmetry in stress processing in rat prefrontal cortex and the role of mesocortical dopamine. Stress 2004 Jun; 7(2): 131–43
  Article PubMed CAS Google Scholar
• Muly EC, Maddox M, Smith Y. Distribution of mGluR1-alpha and mGluR5 immunolabeling in primate prefrontal cortex. J Comp Neurol 2003; 467(4): 521–35
  Article PubMed CAS Google Scholar
• Tooney PA, Au GG, Chahl LA. Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex. Neurosci Lett 2000; 283(3): 185–8
  Article PubMed CAS Google Scholar
• Whitty CJ, Paul MA, Bannon MJ. Neurokinin receptor mRNA localization in human midbrain dopamine neurons. J Comp Neurol 1997; 382(3): 394–400
  Article PubMed CAS Google Scholar
• Marazziti D, Betti L, Giannaccini G, et al. Distribution of [3H]GR65630 binding in human brain postmortem. Neurochem Res 2001 Mar; 26(3): 187–90
  Article PubMed CAS Google Scholar
• Hewlett WA, Fridman S, Trivedi BL, et al. Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MI-ZAC) binding to 5-HT3 receptors in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 1998 Feb; 22(2): 397–410
  Article PubMed CAS Google Scholar
• Hirst WD, Abrahamsen B, Blaney FE, et al. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol 2003 Dec; 64(6): 1295–308
  Article PubMed CAS Google Scholar
• Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993 Aug; 43(8): 1467–72
  Article PubMed CAS Google Scholar
• Raffai RL, Dong LM, Farese Jr RV, et al. Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E. Proc Natl Acad Sci U S A 2001 Sep 25; 98(20): 11587–91
  Article PubMed CAS Google Scholar
• Loring JF, Paszty C, Rose A, et al. Rational design of an animal model for Alzheimer’s disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent. Neurobiol Aging 1996 Mar–Apr; 17(2): 173–82
  Article PubMed CAS Google Scholar
• Tan HY, Callicott JH, Weinberger DR. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb Cortex 2007 Sep; 17Suppl. 1: i171–81
  Article PubMed Google Scholar
• Bertolino A, Caforio G, Blasi G, et al. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 2004 Oct; 161(10): 1798–805
  Article PubMed Google Scholar
• Salminen M, Lundström K, Tilgmann C, et al. Molecular cloning and characterization of rat liver catechol-O-methyltransferase. Gene 1990 Sep 14; 93(2): 241–7
  Article PubMed CAS Google Scholar
• Babovic D, O’Tuathaigh CM, O’Sullivan GJ, et al. Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice. Behav Brain Res 2007 Nov 2; 183(2): 236–9
  Article PubMed CAS Google Scholar
• Meno-Tetang GM, Lowe PJ. On the prediction of the human response: a recycled mechanistic pharmacokinetic/ pharmacodynamic approach. Basic Clin Pharmacol Toxicol 2005 Mar; 96(3): 182–92
  Article PubMed CAS Google Scholar
• Katoh M, Tateno C, Yoshizato K, et al. Chimeric mice with humanized liver. Toxicology 2008 Apr 3; 246(1): 9–17
  Article PubMed CAS Google Scholar
• Kapur S, VanderSpek SC, Brownlee BA, et al. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 2003 May; 305(2): 625–31
  Article PubMed CAS Google Scholar
• Ikonomovic MD, Abrahamson EE, Isanski BA, et al. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease. Arch Neurol 2007 Sep; 64(9): 1312–7
  Article PubMed Google Scholar
• Raschetti R, Albanese E, Vanacore N, et al. Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med 2007 Nov 27; 4(11): e338
  Article PubMed Google Scholar
• Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease. Brain 2007 Nov; 130 Pt 11: 2837–44
  Article Google Scholar
• Korczyn A. The amyloid cascade hypothesis. Alzheimers Dement 2008; 4: 176–8
  Article PubMed CAS Google Scholar
• Forsberg A, Engler H, Almkvist O, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 2008; 29(10): 1456–65
  Article PubMed CAS Google Scholar
• Carpenter WT, Koenig JI. The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology 2008 Aug; 33(9): 2061–79
  Article PubMed CAS Google Scholar
• Abi-Dargham A, Rodenhiser J, Printz D, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 2000 Jul 5; 97(14): 8104–9
  Article PubMed CAS Google Scholar
• Bredeloux P, Dubuc I, Costentin J. Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. Br J Pharmacol 2007 Mar; 150(6): 711–9
  Article PubMed CAS Google Scholar
• Boileau I, Dagher A, Leyton M, et al. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. J Neurosci 2007 Apr 11; 27(15): 3998–4003
  Article PubMed CAS Google Scholar
• Suri RE. TD models of reward predictive responses in dopamine neurons. Neural Netw 2002 Jun–Jul; 15(4–6): 523–33
  Article PubMed Google Scholar
• Wanjerkhede SM, Bapi RS. Modeling the sub-cellular signaling pathways involved in reinforcement learning at the striatum. Prog Brain Res 2008; 168: 193–206
  Article PubMed CAS Google Scholar
• Roberts WA, Feeney MC, Macpherson K, et al. Episodic-like memory in rats: is it based on when or how long ago? Science 2008 Apr 4; 320(5872): 113–5
  Article PubMed CAS Google Scholar
• Skelley SL, Goldberg TE, Egan MF, et al. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophr Res 2008 Oct; 105(1–3): 78–85
  Article PubMed Google Scholar
• Howard AR. Further validation studies of the Wechsler Memory Scale. Clin Psychol 1954 Apr; 10(2): 164–7
  Article CAS Google Scholar
• Traykov L, Raoux N, Latour F, et al. Executive functions deficit in mild cognitive impairment. Cogn Behav Neurol 2007 Dec; 20(4): 219–24
  Article PubMed Google Scholar
• Carlson JM, Doyle J. Highly optimized tolerance: robustness and design in complex systems. Phys Rev Lett 2000 Mar 13; 84(11): 2529–32
  Article PubMed CAS Google Scholar
• Nayak S, Salim S, Luan D, et al. A test of highly optimized tolerance reveals fragile cell-cycle mechanisms are molecular targets in clinical cancer trials. PLoS One 2008 Apr 23; 3(4): e2016
  Article PubMed Google Scholar
• Hagmann P, Cammoun L, Gigandet X, et al. Mapping the structural core of human cerebral cortex. PLoS Biol 2008 Jul 1; 6(7): e159
  Article PubMed Google Scholar
• Sambataro F, Murty VP, Callicott JH, et al. Age-related alterations in default mode network: impact on working memory performance. Neurobiol Aging. Epub 2008 Jul 30
• Winder R, Cortes CR, Reggia JA, et al. Functional connectivity in fMRI: modeling approach for estimation and for relating to local circuits. Neuroimage 2007 Feb 1; 34(3): 1093–107
  Article PubMed Google Scholar
• Kapur S, Zipursky R, Jones C, et al. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 2000 Apr; 157(4): 514–20
  Article PubMed CAS Google Scholar
• Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 2003 Jun; 60(6): 553–64
  Article PubMed CAS Google Scholar
• Stroup T. Heterogeneity of treatment effects in schizophrenia. Am J Med 2007 Apr; 120(4 Suppl. 1): S26–31
  Article PubMed CAS Google Scholar
• Wong EH, Nikam SS, Shahid M. Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges. Curr Opin Investig Drugs 2008 Jan; 9(1): 28–36
  PubMed CAS Google Scholar
• Nudelman A, Gil-Ad I, Shpaisman N, et al. A mutual prodrug ester of GABA and perphenazine exhibits anti-schizophrenic efficacy with diminished extrapyramidal effects. J Med Chem 2008 May 8; 51(9): 2858–62
  Article PubMed CAS Google Scholar
• ClinicalTrials.gov. Available from URL: http://www.clinicaltrials.gov/ct2/results?term=Alzheimer [Accessed 2009 Jul 23]
• Cambridge Healthtech Associates. Our mission [online]. Available from URL: http://www.chacorporate.com/pages/55_our_mission.cfm [Accessed 2009 Jul 23]
• Cambridge Healthtech Associates. Toxicokinetics (TK) optimization [online]. Available from URL: http://www.chacorporate.com/pages/91_toxicokinetics_tk_optimization.cfm [Accessed 2009 Jul 23]
• Montague PR, King-Casas B, Cohen JD. Imaging valuation models in human choice. Annu Rev Neurosci 2006; 29: 417–48
  Article PubMed CAS Google Scholar
• Grill-Spector K, Sayres R, Ress D. High-resolution imaging reveals highly selective nonface clusters in the fusiform face area. Nat Neurosci 2006 Sep; 9(9): 1177–85
  Article PubMed CAS Google Scholar
• Mitchell TM, Shinkareva SV, Carlson A, et al. Predicting human brain activity associated with the meanings of nouns. Science 2008 May 30; 320(5880): 1191–5
  Article PubMed CAS Google Scholar
• Yoshimura M, Koenig T, Irisawa S, et al. A pharmaco-EEG study on antipsychotic drugs in healthy volunteers. Psychopharmacology (Berl) 2007 May; 191(4): 995–1004
  Article CAS Google Scholar
• Ahnaou A, Nayak S, Heylen A, et al. Sleep and EEG profile in neonatal hippocampal lesion model of schizophrenia. Physiol Behav 2007 Oct 22; 92(3): 461–7
  Article PubMed CAS Google Scholar
• Salvadore G, Cornwell BR, Colon-Rosario V, et al. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry 2009 Feb 15; 65(4): 289–95
  Article PubMed CAS Google Scholar
• Holmes HM, Sachs GA, Shega JW, et al. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc 2008 Jul; 56(7): 1306–11
  Article PubMed Google Scholar
• Geerts H. Drug evaluation: (R)-flurbiprofen an enantiomer of flurbiprofen for the treatment of Alzheimer’s disease. IDrugs 2007 Feb; 10(2): 121–33
  PubMed CAS Google Scholar
• Fisher A. M1 muscarinic agonists target major hallmarks of Alzheimer’s disease: the pivotal role of brain M1 receptors. Neurodegener Dis 2008; 5(3–4): 237–40
  Article PubMed CAS Google Scholar
• Menzies L, Ooi C, Kamath S, et al. Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. Arch Gen Psychiatry 2007 Feb; 64(2): 156–67
  Article PubMed CAS Google Scholar
• Kirschner M. The meaning of systems ioilogy. Cell 2005; 121(4): 503–4
  Article PubMed CAS Google Scholar
• Bangs A. Predictive biosimulation and virtual patients in pharmaceutical R and D. Stud Health Technol Inform 2005; 111: 37–42
  PubMed Google Scholar
• Cappuccio A, Elishmereni M, Agur Z. Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model. Cancer Res 2006 Jul 15; 66(14): 7293–300
  Article PubMed CAS Google Scholar
• Hodgkin AL, Huxley AF. A quantitative description of membrane currents and its application to conduction and excitation in nerve. J Physiol 1952; 117(4): 500–44
  PubMed CAS Google Scholar
• De Schutter E. Why are computational neuroscience and systems biology so separate? PLoS Comput Biol 2008 May 30; 4(5): e1000078
  Article PubMed Google Scholar
• Erdi P, Kiss T, Tóth J, et al. From systems biology to dynamical neuropharmacology: proposal for a new methodology. Syst Biol (Stevenage) 2006 Jul; 153(4): 299–308
  Article CAS Google Scholar